18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging for the diagnosis of immune checkpoint inhibitor-associated myocarditis-Reference-Cited by-同舟云学术

18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging for the diagnosis of immune checkpoint inhibitor-associated myocarditis

Published:2022-02 Issue:2 Volume:115 Page:114-116
ISSN:1875-2136
Container-title:Archives of Cardiovascular Diseases
language:en
Short-container-title:Archives of Cardiovascular Diseases

Author:

Ederhy Stéphane,Devos Perrine,Pinna Bruno,Funck-Brentano Elisa,Abbar Baptiste,Fenioux Charlotte,Cohen Ariel A.,Moslehi Javid,Bretagne Marie,Allenbach Yves,Kharroubi Dris,Salem Joe-Elie

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference6 articles.

1. Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study;Salem;Lancet Oncol,2018

2. Myocarditis in the setting of cancer therapeutics: proposed case definitions for emerging clinical syndromes in cardio-oncology;Bonaca;Circulation,2019

3. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis;Blankstein;J Am Coll Cardiol,2014

4. Fulminant myocarditis with combination immune checkpoint blockade;Johnson;N Engl J Med,2016

5. Major adverse cardiovascular events and the timing and dose of corticosteroids in immune checkpoint inhibitor-associated myocarditis;Zhang;Circulation,2020

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complementary use of cardiac magnetic resonance and 18 F-FDG positron emission tomography imaging in suspected immune checkpoint inhibitor myocarditis;Cardio-Oncology;2024-08-22

2. Cardiac Complications of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy;Cardiology Clinics;2024-08

3. Novel tracers to assess myocardial inflammation with radionuclide imaging;Journal of Nuclear Cardiology;2024-07

4. Use of positron emission tomography for the diagnosis of immune-checkpoint inhibitor| myocarditis;Journal of Nuclear Cardiology;2024-07

5. Is 18F-FDG-PET/CT an Optimal Imaging Modality for Detecting Immune-Related Adverse Events after Immune-Checkpoint Inhibitor Therapy? Pros and Cons;Cancers;2024-05-24